Open AccessPerception of various stakeholders regarding clinical drug trial industry in India
Author(s) -
Rakesh Parikh,
Kirti Pandia,
Mahesh Goyal,
Meenakshi Sharma,
M S Dolima
Publication year - 2011
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.83225
Subject(s) - respondent , clinical trial , pace , perception , drug trial , introspection , pharmaceutical industry , medicine , alternative medicine , public relations , business , marketing , medical education , political science , psychology , pharmacology , geography , law , pathology , geodesy , neuroscience , cognitive psychology
Though India has been thought to be an ideal destination for conduct of clinical drug trials, other smaller countries seem to be doing better. The pace of growth observed during 2005-2009 seems to be plateaued in 2010.